Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shichun Tu

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Molecular Neurodegeneration|November 15, 2014
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's diseaseShichun Tu, Shu-ichi Okamoto, Stuart A Lipton, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 17, 2018
Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatmentLingchuan Guo, Pei Lin, Hui Xiong, et al.
Biological Psychiatry|May 4, 2005
A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startleSuzanne A Brody, Nobuki Nakanishi, Shichun Tu, et al.
Journal of Molecular Neuroscience : MN|September 17, 2015
Differential Effects of Pharmacologic and Genetic Modulation of NMDA Receptor Activity on HIV/gp120-Induced Neuronal Damage in an In Vivo Mouse ModelNobuki Nakanishi, Yeon-Joo Kang, Shichun Tu, et al.
International Journal of Oncology|December 3, 2019
Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review)Zunmin Zhu, Tao Li, Xuran Zhang, et al.
Oncotarget|November 16, 2017
Pathologic subtype-defined prognosis is dependent on both tumor stage and status of oncogenic driver mutations in lung adenocarcinomaYu Dong, Ying Li, Bo Jin, et al.
Cancer Biology & Therapy|July 15, 2016
Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case reportYadan Wang, Xiaofei Wu, Jun Deng, et al.
Cancer Biology & Therapy|October 26, 2018
Identification of a novel PDGFRA point mutation at p.P6L as a potential molecular target of imatinib in an eosinophilia patient showing genetic heterogeneityMiaomiao Zhao, Qiuling Wu, Linghui Xia, et al.
Oncology Letters|March 22, 2024
Multi‑omics approach to improve patient‑tailored therapy using immune checkpoint blockade and cytokine‑induced killer cell infusion in an elderly patient with lung cancer: A case report and literature reviewYasi Xing, Fangyuan Qin, Lei Han, et al.
Technology in Cancer Research & Treatment|October 10, 2025
Clinical Potential of Copy Number Aberration as a Diagnostic and Prognostic Biomarker in LymphomaXudong Zhang, Zailin Yang, Susu Yan, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Molecular Neurodegeneration|November 15, 2014
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's diseaseShichun Tu, Shu-ichi Okamoto, Stuart A Lipton, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 17, 2018
Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatmentLingchuan Guo, Pei Lin, Hui Xiong, et al.
Biological Psychiatry|May 4, 2005
A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startleSuzanne A Brody, Nobuki Nakanishi, Shichun Tu, et al.
Journal of Molecular Neuroscience : MN|September 17, 2015
Differential Effects of Pharmacologic and Genetic Modulation of NMDA Receptor Activity on HIV/gp120-Induced Neuronal Damage in an In Vivo Mouse ModelNobuki Nakanishi, Yeon-Joo Kang, Shichun Tu, et al.
International Journal of Oncology|December 3, 2019
Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review)Zunmin Zhu, Tao Li, Xuran Zhang, et al.
Oncotarget|November 16, 2017
Pathologic subtype-defined prognosis is dependent on both tumor stage and status of oncogenic driver mutations in lung adenocarcinomaYu Dong, Ying Li, Bo Jin, et al.
Cancer Biology & Therapy|July 15, 2016
Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case reportYadan Wang, Xiaofei Wu, Jun Deng, et al.
Cancer Biology & Therapy|October 26, 2018
Identification of a novel PDGFRA point mutation at p.P6L as a potential molecular target of imatinib in an eosinophilia patient showing genetic heterogeneityMiaomiao Zhao, Qiuling Wu, Linghui Xia, et al.
Oncology Letters|March 22, 2024
Multi‑omics approach to improve patient‑tailored therapy using immune checkpoint blockade and cytokine‑induced killer cell infusion in an elderly patient with lung cancer: A case report and literature reviewYasi Xing, Fangyuan Qin, Lei Han, et al.
Technology in Cancer Research & Treatment|October 10, 2025
Clinical Potential of Copy Number Aberration as a Diagnostic and Prognostic Biomarker in LymphomaXudong Zhang, Zailin Yang, Susu Yan, et al.
Pageof 4